Avantor(US:AVTR) Prnewswire·2025-10-23 12:05Core Insights - Avantor, Inc. has announced a collaboration with p-Chip Corporation to develop a new generation of "Smart Consumables" that integrate microtransponder technology for enhanced traceability and digital process control in pharmaceutical and clinical workflows [1][2][3] Group 1: Collaboration Details - The partnership aims to leverage Avantor's expertise and scale alongside p-Chip's digital microtransponder technology to meet the needs of strategic customers in life sciences, diagnostics, bio-manufacturing, and healthcare [2][3] - Smart Consumables will include laboratory items such as vials, slides, cassettes, tubes, and plates, each embedded with a durable p-Chip microtransponder that provides a unique identifier for secure tracking [3][4] Group 2: Market Demand and Applications - There is a growing demand for precision and individualized therapies, which necessitates high-fidelity sample traceability and secure Chain-of-Identity (COI) compliance [4] - Personalized therapeutics, including advanced cell and gene therapies, require secure identification and monitoring of patient samples throughout their therapeutic journey [4] Group 3: Strategic Importance - The innovation aligns with Avantor's mission to enable scientific breakthroughs and meet high-value customer needs in personalized medicine [5] - The collaboration is expected to enhance traceability and compliance in laboratory workflows, streamlining quality control and accelerating digital transformation in pharmaceutical and healthcare processes [5]